Peña-Romero AG, Domínguez-Cherit J, Méndez-Flores S

Language: Spanish
References: 24
Page: 703-710
PDF size: 354.58 Kb.

ABSTRACT

Background: Leukemia Cutis (LC) consists in neoplastic leukocytic infiltration of the skin and is strongly associated with the presence of extramedullary disease and poor prognosis. However, there are few studies in the literature regarding this entity. We perform a retrospective study of 27 mexican patients in order to analyze the clinical features and prognosis of LC in Mexico, and a brief review of the literature. Methods: Cases diagnosed as LC by skin biopsy were selected from the database of the Department of Dermatology of National Institute of Medical Science and Nutrition Salvador Zubirán. Cases were searched between the dates of January 1993 and December 2013. Results: Twenty-seven cases which were histologically confirmed with cutaneous leukemic infiltrate were included. Of these patients 60% were male and the mean age at diagnosis was 42 yr (19 to 80 yr). The predominant tipe of LC was acute myeloid leukemia (AML) with 48% of the cases. Nodular neoformations were the main clinical manifestation with 63% of the cases. The mean interval between the diagnosis of LC and death was 10 months (CI 95%). Conclusions: The presence of LC is a marker of poor prognosis and can precede the relapse of systemic leukemia. Cutaneous infiltration may be the first or the only sign of progression, so doctors should be familiar with the clinical manifestations of this disease.

REFERENCES

1. Sánchez-Hernández C, Crespo-Solís E, Rosas-López A, Archer-Dubon C, Orozco-Topete R. Dermatosis en pacientes con leucemia aguda mieloide y linfoide. Seguimiento de una cohorte en un hospital de tercer nivel. RIC. 2011;63(4):353-60.

2. Rodríguez García H, Juárez Navarrete L. Leucemia cutánea. Comunicación de un caso y revisión de la literatura. Dermatología Rev Mex. 2007:51(1):20-4.

3. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008.

4. Wagner G, Fenchel K, Back W, Schulz A, Sachse M. Leukemia cutis – epidemiology, clinical presentation and differential diagnoses. J Dtsch Dermatol Ges. 2012;10(1):27-36.

5. Cho-Vega JH, Medeiros LJ, Prieto VG, Vega F. Leukemia cutis. Am J Clin Pathol. 2008;129:130-42.

6. Patel LM, Maghari A, Schwartz RA, Kapila R, Morgan AJ, Lambert C. Myeloid leukemia cutis in the setting of myelodysplastic syndrome: a crucial dermatological diagnosis. Int J Dermatol. 2012;51(4):383-8.

7. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937-51.

8. Yeon Soo Kang, Hei Sung Kim, Hyun Jeong Park, Jun Young Lee, Hyung Ok Kim, Baik Kee Cho, et al. Clinical Characteristics of 75 Patients with Leukemia Cutis. J Korean Med Sci. 2013;28:614-9.

9. Giralt S, O’Brien S, Weeks E, Luna M, Kantarjian H. Leukemia cutis in acute promyelocytic leukemia: report of three cases after treatment with all-transretinoic acid. Leuk Lymphoma. 1994;14:453-6.

10. Petrella T, Meijer CJ, Dalac S, Willemze R, Maynadié M, Machet L, et al. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis. Am J Clin Pathol. 2004;122:307-13.

11. Gambichler T, Herde M, Hoffmann K, Altmeyer P, Jansen T. Poor prognosis of acute myeloid leukemia associated with leukemia cutis. J Eur Acad Dermatol Venereol. 2002;16(Suppl 2):177-8.

12. Watson KM, Mufti G, Salisbury JR. Spectrum of clinical presentation, treatment and prognosis in a series of eight patients with leukemia cutis. Clin Exp Dermatol. 2006;31:218-21.

13. Agis H, Weltermann A, Fonatsch C, Haas O, Mitterbauer G, Müllauer L, et al. A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis. Ann Hematol. 2002;81(2):90-5.

14. De la Barreda F. Consulta dermatológica en pacientes con neoplasias dermatológicas. Dermatología Rev Mex. 1999;43:255-9.

15. Angulo J, Haro R, González-Guerra E, Fariña MC, Martín L, Requena L. Leukemia cutis presenting as localized cutaneous hyperpigmentation. J Cutan Pathol. 2008;35:662-5.

16. Cuñeto J, Meseguer-Yebra C, Román-Curto C, Santos-Briz A, Fernández- López E, Fraile C, et al. Leukemic vasculitis: a rare pattern of leukemia cutis. J Cutan Pathol. 2011;38:360-4.

17. Starnes AM, Kast DR, Lu K, Honda K. Leukemia Cutis Amidst a Psoriatic Flare: A Case Report. Am J Dermatopathol. 2012;34:292-4.

18. di Meo N, Stinco G, Trevisan G. Cutaneous B-cell chronic lymphocytic leukemia resembling a granulomatous rosacea. Dermatol Online J. 2013;19(10):20033.

19. Sharma SK, Gupta S, Seth T, Mishra P, Mahapatra M, Singh MK, et al. Leukemia cutis: an unusual presentation. Indian J Hematol Blood Transfus. 2012;28(3):175-7.

20. Maughan C, Kolker S, Markus B, Young J. Leukemia Cutis Coexisting with Dermatofibroma as the Initial Presentation of B-cell Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Am J Dermatopathol. 2014;36(1):e14-5.

21. Cerroni L, Höfler G, Bäck B, Wolf P, Maier G, Kerl H. Specific cutaneous infiltrates of B-Cell chronic lymphocytic leukemia (B-CLL) at sites typical for Borrelia burgdorferi infection. J Cutan Pathol. 2002;29:142.

22. Desch JK, Smoller BR. The spectrum of cutaneous disease in leukemias. J Cutan Pathol. 1993;20:407-10.

23. Zweegman S, Vermeer MH, Bekkink MW, van der Valk P, Nanayakkara P, Ossenkoppele GJ. Leukemia cutis: clinical features and treatment strategies. Haematologica. 2002;87:(04)ECR13.

24. Ratterman M, Kruczek K, Sulo S, Shanafelt TD, Kay NE, Nabhan C. Extramedullary chronic lymphocytic leukemia: Systematic analysis of cases reported between 1975 and 2012. Leuk Res. 2014;38(3):299-303.